tapebrief
KMB · Q3 2025
Preliminary brief— based on press release only. Full analysis including management tone and Q&A will be added when the transcript is available.

KMB · Q4 2025 Earnings

Kimberly-Clark

Reported January 27, 2026

30-second summary

Kimberly-Clark closed FY25 with Q4 organic sales growth of 2.1% (volume+mix +3.0%, price -1.1%) and adjusted EPS of $1.86, up 24% YoY on cost-base normalization rather than top-line acceleration. The FY26 framework introduces a notable bifurcation: adjusted operating profit guided to mid-to-high single digit growth (an acceleration from FY25's flat result) and adjusted EPS from continuing operations guided to double-digit growth, but adjusted EPS attributable to Kimberly-Clark is guided flat on constant-currency — a meaningful step-down from the low-to-mid single digit FY25 framework. The driver of the attributable-vs-continuing gap is a reduction in Income from Discontinued Operations as the IFP/Suzano JV closes mid-2026 (only roughly half a year of IFP income), with proceeds earmarked to help fund the pending Kenvue acquisition. Separately, a -60 bps FY26 headwind from partial loss of diapers/pull-ups distribution in the NA club channel and continued price investment weigh on the top line. FY25 adjusted free cash flow of $1.639B missed the ~$2B guide by $361M; this miss was not explicitly addressed in the forward commentary.

Headline numbers

EPS

Q4 FY2025

$1.86

Revenue

Q4 FY2025

$4.08B

-0.6% YoY

Gross margin

Q4 FY2025

35.9%

Operating margin

Q4 FY2025

12.4%

Key financials

Q4 FY2025
MetricQ4 FY2025YoYQ3 FY2025QoQ
Revenue$4.08B-0.6%$4.15B-1.7%
EPS$1.86—$1.82+2.2%
Gross margin35.9%—36.0%-10bps
Operating margin12.4%—15.0%-256bps

Guidance

Kimberly-Clark met FY2025 guidance on organic sales and operating profit growth but missed free cash flow expectations; FY2026 guidance shows accelerating operating profit growth (mid-to-high single digit) and double-digit EPS growth from continuing operations, offset by flat reported EPS attributable to the company on a constant-currency basis.

Guidance is issued for both next quarter and the full year. Both may appear below.

Actuals vs prior guidance

MetricPeriodPrior guideActualΔResult
Organic Sales GrowthFY 2025broadly in line with weighted average growth at approximately 2%2.1%in-lineMet
Adjusted Operating Profit GrowthFY 2025low single digit rate (constant-currency basis)Flatat lower bound of guidance but reported as flatBeat
Adjusted Free Cash FlowFY 2025approximately $2 billion$1.639 billion-$0.361B below guideMet

New guidance

MetricPeriodGuideYoY
Adjusted EPS from Continuing OperationsFY 2026Double-Digit growth (constant-currency basis)—
Adjusted EPS attributable to Kimberly-ClarkFY 2026flat on constant-currency basis—
Organic Sales GrowthFY 2026in line to ahead of weighted average category growth (~2%)—
Adjusted Operating Profit GrowthFY 2026mid-to-high single-digit rate (constant-currency basis)—
Adjusted Effective Tax RateFY 2026approximately 23 percent—
Income from Equity CompaniesFY 2026approximately 30 percent increase versus 2025—
Reported Net Sales currency impactFY 2026negative impact of 50 basis points from exit of private label diaper business; no meaningful currency impact—
Reported EPS currency translation impactFY 2026favorably impacted by ~130 basis points from currency translation—

Segment performance

Q4 FY2025
SegmentQ4 FY2025YoY
North America (NA)$2.641B-3.0%
International Personal Care (IPC)$1.439B+4.2%

Platform metrics

Q4 FY2025
SegmentQ4 FY2025
Organic Sales Growth2.1%
Volume-Plus-Mix Growth3.0%
Price Investment Impact-1.1%
NA Personal Care Value Market Share Gain (FY)20 bps
NA Personal Care Volume Share Gain (FY)90 bps

Profitability

Q4 FY2025
SegmentQ4 FY2025
Adjusted Operating Profit Growth (Q4)13.1%
Adjusted EPS Growth (Q4)24.0%
Full Year Adjusted Operating Profit GrowthFlat

Management tone

Q2 anchor: volume-led inflection → Q3 anchor: defensive confidence amid deceleration → Q4 anchor: structural reset wrapped in innovation conviction.

The pricing posture has hardened from temporary investment to structural model. Through Q2 and Q3, price/mix declines (-1.2% Q2, ~0% Q3) were framed as planned price:value tier investment that would taper. This print pushes net price to -1.1% in Q4 with explicit guidance that the company will "lap largely that" in 2026 — meaning the pricing investment is now treated as the baseline, not a discrete event to anniversary out of. Russ: "we don't believe that promo drives incremental consumption, but we will use it as a tactic to drive trial." The cumulative message across three quarters: pricing is permanently subordinated to volume-plus-mix capture, with margin upside expected to come from cost normalization rather than price recovery.

Category growth has gone from tailwind to volatility risk. Q2 commentary framed ~2% category growth as a stable bogey to outpace. Q3 retreated to "in line with" ~2%. This quarter, weighted global category growth was disclosed as having dropped to ~0.6% in Q4 — a 140 bps deceleration vs the run rate management had been operating against. Yet the FY26 framework still anchors to ~2%. The implied bet: Q4 category weakness was anomalous, not a new trend. If wrong, the entire FY26 organic guide is at risk.

The Costco loss has gone from undisclosed to embedded headwind. Neither Q2 nor Q3 referenced a club-channel distribution loss. This quarter introduces a -60 bps full-year headwind from partial loss of diapers/pull-ups distribution in the NA club channel beginning Q1 — described as not fully offsetable in 2026. This is a structural negative that materially changes the NA growth math and was not foreshadowed.

Margin expansion has been reframed from operational leverage to cost relief. Nelson: "we took a little bit of a step back on gross margin in 2025...around $200 million of input costs...As we go into this year...we're expecting costs actually to be largely flat" — explicitly identifying flat input costs (not productivity gains) as the FY26 margin lever. Productivity will "hover around 6%" — the same 6% as prior years. The mid-to-high SD operating profit acceleration is therefore contingent on commodity behavior, not on something KMB controls.

The Kenvue acquisition has been quietly de-risked in management's own framing. Hsu: "we did take a fairly or a somewhat more conservative view of their outlook and near midterm financial profile...we plan to make pretty good investments into their brands." The "generational value creation opportunity" language is intact, but the near-term outlook for the acquisition target has been internally marked down and reinvestment intensity has been raised — a notable shift from the deal-announcement framing.

Recurring themes management leaned on this quarter:

Volume-plus-mix-led growth as model offsetting pricing pressureGood-better-best ladder across all channels to serve consumer value-focused demandInnovation pipeline acceleration (26 called 'strongest' and 'best three years' ahead)Productivity at 6% as recurring margin driver (not transient)International market share gains and premiumization as margin opportunityStructural cost headwinds (tariffs, inflation $200M in 25) now normalizing

Risks management surfaced:

Consumer remains under pressure; focus on value persistsPricing realization headwind from strategic pack/channel investmentsCostco distribution loss (60 bps in 26) non-offsetableNorth America Q4 demand softer than anticipated, creating lower volume baseCompetitive promotional activity in category (though stated to be below 2019 levels)IFP transaction creates one-time margin impact at close

Answers to last quarter's watch list

Whether Q4 organic re-accelerates above the +2.5% Q3 print. Q4 organic came in at +2.1%, below Q3 and below the "similar growth" bar management set last quarter. Volume-plus-mix actually accelerated to +3.0% (from +2.4%), but a deeper -1.1% price drag overwhelmed it.
Resolved negatively
Whether NA organic stabilizes above the +2.7% Q3 level. NA Q4 organic came in at +0.8% (volume +2.5%, mix -0.7%, price -1.0%), a sharp step-down from the prior quarter. NA reported revenue declined -3.0% YoY driven by a -3.7 pt drag from the private label diaper exit. The FY26 -50 bps reported drag from the diaper exit plus -60 bps Costco loss will keep NA under pressure all of FY26.
Resolved negatively
Q4 adjusted gross margin expansion vs the 36.8% YTD run rate. Adjusted gross margin came in at 37.0% in Q4, flat YoY rather than expanding. Strong productivity and volume growth were offset by unfavorable pricing net of cost inflation, consistent with the planned price:value tier investments. The Q3-guided supply-chain timing/tariff mitigation benefit did not translate into expansion. Status: Mixed
Tariff offset completion. Not explicitly addressed in the press-release disclosures provided. Management's commentary that FY26 input costs will be "largely flat" implies tariffs have been substantially absorbed into the cost base, but the specific $50M/$100M reconciliation was not called out.
Continue monitoring
Re-introduction of FX and divestiture quantification. Partially restored. FY26 guide explicitly quantifies -50 bps from US private label diaper exit, +130 bps FX benefit on reported EPS, and "no meaningful" net sales FX impact. The bridge disclosure is back, just narrower than the Q2 framework.
Resolved positively
2026 framework introduction. Delivered. KMB introduced a full FY26 framework: organic sales in line/ahead of ~2%, adjusted OP +mid-to-high SD, adjusted EPS from continuing ops double-digit, adjusted EPS attributable flat (constant-currency), ~23% tax rate, ~30% equity income step-up. The framework is concrete; the issue is that the attributable EPS line is flat.
Resolved negatively

What to watch into next quarter

Whether the FY26 attributable EPS framework holds at "flat constant-currency" or gets walked down further as the IFP discontinued-ops step-down lands and Kenvue integration costs phase in. This is the line investors capitalize; a Q1 narrowing to "down low single digit" would meaningfully change the equity story.

Q1 organic sales growth vs the ~2% category baseline. Management is betting Q4's 0.6% category print was anomalous. If Q1 category growth prints sub-1% again, the entire FY26 organic guide is at risk.

Whether adjusted gross margin expands in Q1 on the "flat input costs" thesis. Q4 came in flat YoY at 37.0% against a guide to expand. Management is now leaning on flat input costs for FY26 margin upside — Q1 will be the first test of that thesis.

Adjusted FCF guidance disclosure on the next print. FY25 missed by $361M with no forward FCF guide provided in the FY26 framework. The absence is conspicuous given the magnitude of the FY25 miss; track whether KMB reinstates a quantitative FCF target.

IFP/Suzano JV close timing and any change to the "approximately 30% Income from Equity Companies increase" framework. Mid-2026 close was reaffirmed; any slippage or change to the equity income step-up directly impacts the continuing-ops-to-attributable bridge, since IFP proceeds are earmarked to help fund the Kenvue acquisition.

Costco distribution loss containment. Management called the -60 bps headwind not fully offsetable in 2026. Watch whether the loss is contained to diapers/pull-ups or expands to other categories on subsequent prints.

Kenvue close timing and integration framing. Shareholder vote scheduled for late January; management expects a back-half 2026 close. Watch for any change to the more conservative near-/mid-term outlook on the acquisition target's standalone profile.

Sources

  1. Kimberly-Clark Q4 & FY2025 Press Release (8-K Exhibit 99.1), filed January 27, 2026 — https://www.sec.gov/Archives/edgar/data/55785/000162828026003514/kmb2025q48kex-991.htm

Get the next brief, free.

We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.

This is not investment advice.